メニュー
JP | JPY
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
JP | JPY
Sorry, we couldn't find anything on our website containing your search term.
Streamlining Process Scale-Up with the New Eppendorf BioFlo® 720 Bioprocess Controller
news
- プレスリリース
Eppendorf expands integrated upstream bioprocess single-use solutions
Hamburg, January 14, 2021
Streamlining the transfer of an upstream bioprocess from research to production scale is critical for reducing biologics development costs and time to market. Eppendorf, a leading life science company, introduces the BioFlo 720, a bioprocess control station for applications at pilot/production scale using single-use bioreactors. With it, Eppendorf now offers one of the most scalable and comprehensive single-use portfolios on the market, for seamless process scale-up from R&D labs to pilot and manufacturing facilities.
“The BioFlo 720 is compatible with Thermo Fisher Scientific™ HyPerforma™ 5:1 single-use bioreactors. In combination with our BioBLU® Single-Use Vessels for small and bench scale bioprocesses we offer pharmaceutical and biotech companies the benefit of an integrated scalable portfolio, including manufacturing solutions for regulated environments," says Dr. Karl Rix, Vice President of the Bioprocess Business Unit at Eppendorf.
Innovative software features help saving time, increase efficiency and reproducibility by automating repetitive process steps:
With a narrow footprint of only 81 x 87 cm (32” x 34”) the BioFlo 720 minimizes space utilization. Designed as a mobile controller it can be quickly deployed into any bioprocess project in research or regulated environments.
For more information on the BioFlo 720 visit www.eppendorf.com/bioflo720.
Streamlining the transfer of an upstream bioprocess from research to production scale is critical for reducing biologics development costs and time to market. Eppendorf, a leading life science company, introduces the BioFlo 720, a bioprocess control station for applications at pilot/production scale using single-use bioreactors. With it, Eppendorf now offers one of the most scalable and comprehensive single-use portfolios on the market, for seamless process scale-up from R&D labs to pilot and manufacturing facilities.
“The BioFlo 720 is compatible with Thermo Fisher Scientific™ HyPerforma™ 5:1 single-use bioreactors. In combination with our BioBLU® Single-Use Vessels for small and bench scale bioprocesses we offer pharmaceutical and biotech companies the benefit of an integrated scalable portfolio, including manufacturing solutions for regulated environments," says Dr. Karl Rix, Vice President of the Bioprocess Business Unit at Eppendorf.
Innovative software features help saving time, increase efficiency and reproducibility by automating repetitive process steps:
- Auto Inflate automatically controls the inflation process for flexible single-use bioreactors
- Auto Calibrate automatically calibrates all attached DO sensors at once
- Scale Up Assist calculates scaling-relevant parameters based on constant tip speed or power input per volume
With a narrow footprint of only 81 x 87 cm (32” x 34”) the BioFlo 720 minimizes space utilization. Designed as a mobile controller it can be quickly deployed into any bioprocess project in research or regulated environments.
For more information on the BioFlo 720 visit www.eppendorf.com/bioflo720.
もっと読む
Downloads:
Press Release
PDF 0.28 MB
HighRes Image
JPG 3.20 MB